Ember Therapeutics Stock Forecast for 2023 - 2025 - 2030
Updated on 05/16/2024
Ember Therapeutics Fair Value Forecast for 2023 - 2025 - 2030
Ember Therapeutics's Price has grown In the last two years, rising from $0.00 to $0.00 – a growth of 100.00%. In the next year, analysts believe that Fair Value will reach $0.00 – an increase of 100.00%. For the next seven years, experts predict that Ember Therapeutics's Fair Value will grow at a rate of 100.00%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
LLY Stock Forecast | Eli Lilly and | Outperform |
16
|
$787.02 | Buy/Sell | $636.99 | 11.50% |
JNJ Stock Forecast | Johnson & Johnson | Outperform |
9
|
$152.67 | Buy/Sell | $174.55 | 11.35% |
MRK Stock Forecast | Merck | Outperform |
2
|
$131.73 | Buy/Sell | $130.51 | 8.56% |
PFE Stock Forecast | Pfizer | Outperform |
2
|
$28.82 | Buy/Sell | $32.87 | 5.83% |
VRTX Stock Forecast | Vertex Pharmaceuticals Inc | Outperform |
12
|
$437.49 | Buy/Sell | $457.59 | 4.51% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
REGN Stock Forecast | Regeneron Pharmaceuticals | Outperform |
2
|
$978.21 | Buy/Sell | $961.26 | 7.34% |
BMY Stock Forecast | Bristol-Myers Squibb | Hold |
2
|
$44.55 | Buy/Sell | $58.15 | 21.21% |
ZTS Stock Forecast | Zoetis | Outperform |
18
|
$173.28 | Buy/Sell | $220.47 | 26.96% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
ALNY Stock Forecast | Alnylam Pharmaceuticals Inc | Outperform |
7
|
$147.40 | Buy/Sell | $245.24 | 47.56% |
BAX Stock Forecast | Baxter International Inc | Hold |
17
|
$35.43 | Buy/Sell | $44.86 | 24.19% |
VTRS Stock Forecast | Viatris Inc | Hold |
8
|
$11.07 | Buy/Sell | $11.73 | 8.40% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
UTHR Stock Forecast | United Therapeutics | Outperform |
12
|
$272.69 | Buy/Sell | $284.08 | 10.02% |
CTLT Stock Forecast | Catalent | Hold |
15
|
$55.61 | Buy/Sell | $49.29 | 14.19% |
CYTK Stock Forecast | Cytokinetics | Outperform |
10
|
$60.50 | Buy/Sell | $87.92 | 55.37% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
IONS Stock Forecast | Ionis Pharmaceuticals | Outperform |
9
|
$39.21 | Buy/Sell | $55.60 | 53.02% |
BCPC Stock Forecast | Balchem | Outperform |
18
|
$156.36 | Buy/Sell | $145.00 | 5.53% |
MDGL Stock Forecast | Madrigal Pharmaceuticals | Outperform |
4
|
$211.73 | Buy/Sell | $315.92 | 82.31% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
PRGO Stock Forecast | Perrigo Co PLC | Outperform |
16
|
$30.22 | Buy/Sell | $44.75 | 32.36% |
NEOG Stock Forecast | Neogen | Outperform |
16
|
$13.30 | Buy/Sell | $37.00 | 27.82% |
CORT Stock Forecast | Corcept Therapeutics | Buy |
16
|
$27.83 | Buy/Sell | $35.67 | 43.73% |
Ember Therapeutics EPS Price Prediction Forecast for 2023 - 2025 - 2030
Ember Therapeutics's EPS has grown In the last two years, rising from $0.00 to $0.00 – a growth of 100.00%. In the next year, analysts believe that EPS will reach $0.00 – an increase of 100.00%. For the next seven years, experts predict that Ember Therapeutics's EPS will grow at a rate of 100.00%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
INDV Stock Forecast | Indivior PLC | Buy |
14
|
£13.85 | Buy/Sell | £28.89 | 123.32% |
TGTX Stock Forecast | TG Therapeutics | Outperform |
9
|
$17.72 | Buy/Sell | $29.44 | 94.70% |
AMPH Stock Forecast | Amphastar Pharmaceuticals | Outperform |
14
|
$42.44 | Buy/Sell | $69.00 | 46.09% |